Literature DB >> 12849392

Global democratic consensus on neuropathological disease criteria.

Cristian Achim, Roland Auer, Catherine Bergeron, Adriana Cardozo, Manuel Deprez, Rob de Vos, Charles Duyckaerts, Rupert Egensperger, Margaret Esiri, Matthew P Frosch, Caterina Giannini, Hans H Goebel, Manuel B Graeber, David I Graham, Francoise Gray, Matti Haltia, Yoshio Hashizume, Kenji Ikeda, James W Ironside, Georg W Kreutzberg, Peter Lantos, James Lowe, Samuel Ludwin, Yoh Matsumoto, Yngve Olsson, Atsushi Sasaki, Bernd W Scheithauer, Hitoshi Takahashi, Markus Tolnay, John Q Trojanowski, Dirk Troost, Henry de F Webster.   

Abstract

Entities:  

Mesh:

Year:  2002        PMID: 12849392     DOI: 10.1016/s1474-4422(02)00156-4

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  3 in total

1.  Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition.

Authors:  Emilie Croisier; Linda B Moran; David T Dexter; Ronald K B Pearce; Manuel B Graeber
Journal:  J Neuroinflammation       Date:  2005-06-03       Impact factor: 8.322

2.  Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium.

Authors:  Irina Alafuzoff; Thomas Arzberger; Safa Al-Sarraj; Istvan Bodi; Nenad Bogdanovic; Heiko Braak; Orso Bugiani; Kelly Del-Tredici; Isidro Ferrer; Ellen Gelpi; Giorgio Giaccone; Manuel B Graeber; Paul Ince; Wouter Kamphorst; Andrew King; Penelope Korkolopoulou; Gábor G Kovács; Sergey Larionov; David Meyronet; Camelia Monoranu; Piero Parchi; Efstratios Patsouris; Wolfgang Roggendorf; Danielle Seilhean; Fabrizio Tagliavini; Christine Stadelmann; Nathalie Streichenberger; Dietmar R Thal; Stephen B Wharton; Hans Kretzschmar
Journal:  Brain Pathol       Date:  2008-03-26       Impact factor: 6.508

3.  A free community approach to classifying disease.

Authors:  Manuel B Graeber; James Lowe; Bishan Radotra
Journal:  PLoS Med       Date:  2004-11-30       Impact factor: 11.069

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.